PR-619
-
PR-619
structure -
-
CAS No:
2645-32-1
-
Formula:
C7H5N5S2
-
Chemical Name:
PR-619
-
Synonyms:
PR-619;2,6-DiaMino-3,5-dithiocyanopyridine;3,5-dithiocyanatopyridine-2,6-diaMine;Thiocyanic acid, C,C'-(2,6-diamino-3,5-pyridinediyl) ester;2,6-Diamino-3,5-dithiocyanopyridinePR 619;PR 619 2,6-Diamino-3,5-dithiocyanopyridine;2,6-Diaminopyridine-3,5-bis(thiocyanate);PR-619, >=98%
- Categories:
-
CAS No:
Description
PR-619 is a broad-range DUB inhibitor with EC50 of 3.93, 4.9, 6.86, 7.2, and 8.61 μM for USP4, USP8, USP7, USP2, and USP5, respectively.
Characteristics
163
1.3
white to beige
1.6±0.1 g/cm3
210℃
199.3±28.7 °C
1.764
DMSO: soluble5mg/mL (clear solution)
-20°C
Safety Information
NONH for all modes of transport
3
22-37/38-41-43
26-36/37/39
Xn
P261-P280-P305 + P351 + P338
H302-H315-H317-H318-H335
|Danger|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P272, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P333+P313, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 39 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
PR-619 Use and Manufacturing
PR 619 is a broad-range DUB inhibitor. A selective and general inhibitior of cellular DUB activity without direct impairment of proteasomal proteolysis. Used in the preparation of thiazolopyridines and bisthiazolopyridines.
Computed Properties
Molecular Weight:223.3
XLogP3:1.3
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:2
Exact Mass:222.99863753
Monoisotopic Mass:222.99863753
Topological Polar Surface Area:163
Heavy Atom Count:14
Complexity:261
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of PR-619
-
US
YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates
Learn More Other Chemicals
-
Sodium phenylbutyrate
1716-12-7
-
Afatinib dimaleate
850140-73-7
-
Idelalisib
870281-82-6
-
Lenvatinib mesylate Formula
857890-39-2
-
Silodosin Formula
160970-54-7
-
Teneligliptin Hydrobromide Formula
906093-29-6
-
3-[1-[3-(Dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione Structure
133052-90-1
-
2-[4-[[[2-[3-Fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy]acetic acid Structure
317318-84-6
-
What is Cabozantinib
849217-68-1
-
What is Dacomitinib
1110813-31-4